GSK2879552

Ligand id: 9116

Name: GSK2879552

Structure and Physico-chemical Properties

2D Structure
Calculated Physico-chemical Properties
Hydrogen bond acceptors 4
Hydrogen bond donors 2
Rotatable bonds 7
Topological polar surface area 52.57
Molecular weight 364.22
XLogP 5.67
No. Lipinski's rules broken 1

Molecular properties generated using the CDK

Classification
Compound class Synthetic organic
IUPAC Name
4-[[4-[[[(1R,2S)-2-phenylcyclopropyl]amino]methyl]piperidin-1-yl]methyl]benzoic acid
Synonyms
Example 26 [WO2012135113] | GSK-2879552
Database Links
PubChem CID 66571643
Search Google for chemical match using the InChIKey LRULVYSBRWUVGR-FCHUYYIVSA-N
Search Google for chemicals with the same backbone LRULVYSBRWUVGR
Search UniChem for chemical match using the InChIKey LRULVYSBRWUVGR-FCHUYYIVSA-N
Search UniChem for chemicals with the same backbone LRULVYSBRWUVGR
Comments
GSK2879552 is an investigational, orally available, irreversible inhibitor of lysine specific demethylase 1 (LSD1; officially known as lysine demethylase 1A, KDM1A), with potential to modulate epigenetic regulation in cancer. GSK2879552-induced LDS1 inhibition causes expression of proteins indicative of a differentiated immunophenotype. GSK2879552 is Example 26 claimed in patent WO2012135113 [1].